CBG

Geocann Is First-to-Market Introducing Cannabigerol (CBG) Formulations Utilizing the VESIsorb® Drug Delivery System

The first of two formulations is a combination of CBG and cannabidiol (CBD) while the second is a mono-CBG formulation

MANUFACTURING

Geocann Appoints Medical and Scientific Advisory Board to Expand Its Leadership Position in Research and Innovation

Members have prominent careers focused on advancing the therapeutic benefits of science-backed natural ingredients, like cannabinoids and terpenes

CONSUMABLES

Geocann Launches Patent-Protected Cannabis Formulations for Rapid Uptake Edible and Beverage Products

New formulations allow leading brands to deliver the safest and most efficacious cannabis food and beverage products with fast-acting and predictable onset

CBD

Atrium Innovations Launches VESIsorb® Formulated Hemp Products Under Industry Leading Brands

Atrium Innovations to market Geocann CBD soft gel formulations under the healthcare brands Pure Encapsulations, Douglas Laboratories and Genestra Brands

CBD
1

Respected Neurosurgeon Brings Distinguished Career and Medical Expertise to Geocann’s Executive Management Team

Anthony Petraglia MD joins Geocann as Chief Medical Officer and will serve as Chairman of the company’s Scientific and Medical Advisory Board

MANUFACTURING
1

Geocann Announces Proven Stability Data Ensuring Desired Levels of Active Ingredients Are Maintained Throughout Promised Shelf-Life

While many cannabinoid products fall short of label claims, Geocann’s data confirms the VESIsorb® delivery system maintains key cannabinoids and terpenes

CBD
1

Geocann Launches Cannabidiol (CBD) Soft Gel Formulations Utilizing Patented Drug Delivery Technology

Geocann has successfully commercialized the first formulation of CBD soft gel products that utilize the multi-patented VESIsorb® delivery system

MANUFACTURING
1

Geocann Introduces Patent-Protected VESIsorb® Formulated Cannabis Products to the Global Marketplace

Geocann leverages robust intellectual property portfolio by applying patented drug delivery system technologies to cannabinoid formulations